ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Berlin-based Atlas Bio raised $11 million in seed funding led by Creandum, bringing total capital to $13.2 million. The company uses the capital to scale human biology data pipelines and expand engineering teams in Germany to accelerate commercial partnerships for its AI-driven in silico trial software.
Tap to vote and see what everyone thinks.
Summary by ByteBrief